When is NIPD currently being used in prenatal diagnosis?
NIPD is presently offered to women whose babies are at risk of Haemolytic Disease of the Newborn (HDN) or a genetic disease in which only affects a particular sex e.g. Duchenne Muscular Dystrophy. See our patient information leaflet which explains how the test works and explores how SAFE is making a real difference to parents by dramatically reducing rates of invasive testing.
